Fuente | Nº Citas | Fecha Actualización |
---|---|---|
wos | 0 | 30-10-2024 |
Año: 2021
Journal Impact Factor (JIF): 4.2680
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
HEMATOLOGY | SCIE | 34/78 | Q2 | T2 | D5 |
Año: 2021
Journal Citation Indicator (JCI): 0,630
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
HEMATOLOGY | 42/94 | Q2 | T2 | D5 | 55,85 |
Año:
2021
CiteScore:
5,100
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Hematology | 43/126 | Q2 | T2 | D4 |
Genetics (clinical) | 41/86 | Q2 | T2 | D5 |
SJR año:
2021
Factor de Impacto:
1,449
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Medicine (miscellaneous) | 241/2548 | Q1 | T1 | D1 |
Genetics (clinical) | 19/103 | Q1 | T1 | D2 |
Hematology | 21/141 | Q1 | T1 | D2 |
# | Autor | Afiliación |
---|---|---|
1 | Kenet, G | Tel Aviv University; Chaim Sheba Medical Center (Israel) |
2 | Chen, YC | Tri-Service General Hospital (Taiwan) |
3 | Lowe, G | University of Birmingham (England) |
4 | Percy, C | University of Birmingham (England) |
5 | Tran, H | Florey Institute of Neuroscience & Mental Health (Australia) |
6 | von Drygalski, A | Scripps Research Institute (USA) |
7 | Trossaërt, M | CHU de Nantes (France) |
8 | Reding, M | University of Minnesota Twin Cities (USA) |
9 | Oldenburg, J | University of Bonn; University Hospital Bonn Institute for Experimental Hematology and Transfusion Medicine (Germany) |
10 | Castellano, MM | Reg Univ Hosp (Spain) |
11 | Park, YS | Kyung Hee University Hospital (South Korea) |
12 | Peyvandi, F | University of Milan (Italy) |
13 | Quinn, J | BioMarin Pharmaceutical Inc. (USA) |
14 | Mitchell, N | BioMarin Pharmaceutical Inc. (USA) |
15 | Huang, M | BioMarin Pharmaceutical Inc. (USA) |
16 | Kim, B | BioMarin Pharmaceutical Inc. (USA) |